Literature DB >> 9220156

Preparation of a monoclonal antibody specific for Entamoeba dispar and its ability to distinguish E. dispar from E. histolytica.

H Tachibana1, S Kobayashi, Y Kaneda, T Takeuchi, T Fujiwara.   

Abstract

A monoclonal antibody (MAb), MAb ED17 (immunoglobulin G2a [IgG2a]), prepared against trophozoites of Entamoeba dispar SAW1734RclAR cultured monoxenically with Crithidia fasciculata, reacted with 25 of 26 isolates of E. dispar by an indirect fluorescent-antibody test. In contrast, the MAb failed to react with any of 20 isolates of E. histolytica or other enteric protozoan parasites. Western blot (immunoblot) analysis showed that the molecular mass of the E. dispar antigen recognized by the MAb was 160 kDa under reduced conditions. Immunoelectron microscopy revealed that the antigen was mainly located on digested C. fasciculata, but not on undigested organisms. Double staining with a mixture of MAb ED17 and MAb 4G6 (an IgG1 MAb which reacts exclusively with E. histolytica), followed by incubation with a mixture of fluorescein isothiocyanate-labeled anti-mouse IgG2a and tetramethylrhodamine isothiocyanate-labeled anti-mouse IgG1 antibodies, simultaneously identified mixed populations of E. dispar and E. histolytica. This method may prove to be useful for the accurate identification of E. dispar and E. histolytica, even in mixed infections.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9220156      PMCID: PMC170542          DOI: 10.1128/cdli.4.4.409-414.1997

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  32 in total

1.  Distinguishing pathogenic isolates of Entamoeba histolytica by polymerase chain reaction.

Authors:  H Tachibana; S Kobayashi; M Takekoshi; S Ihara
Journal:  J Infect Dis       Date:  1991-10       Impact factor: 5.226

2.  Reactivity of monoclonal antibodies to species-specific antigens of Entamoeba histolytica.

Authors:  H Tachibana; S Kobayashi; K Nagakura; Y Kaneda; T Takeuchi
Journal:  J Protozool       Date:  1991 Jul-Aug

3.  Zymodeme conversion of isolates of Entamoeba histolytica.

Authors:  B J Andrews; L Mentzoni; B Bjorvatn
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jan-Feb       Impact factor: 2.184

4.  Pathogenic and nonpathogenic strains of Entamoeba histolytica can be differentiated by monoclonal antibodies to the galactose-specific adherence lectin.

Authors:  W A Petri; T F Jackson; V Gathiram; K Kress; L D Saffer; T L Snodgrass; M D Chapman; Z Keren; D Mirelman
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

5.  Differences in genomic DNA sequences between pathogenic and nonpathogenic isolates of Entamoeba histolytica identified by polymerase chain reaction.

Authors:  H Tachibana; S Ihara; S Kobayashi; Y Kaneda; T Takeuchi; Y Watanabe
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

6.  Diagnosis of pathogenic Entamoeba histolytica infection using a stool ELISA based on monoclonal antibodies to the galactose-specific adhesin.

Authors:  R Haque; K Kress; S Wood; T F Jackson; D Lyerly; T Wilkins; W A Petri
Journal:  J Infect Dis       Date:  1993-01       Impact factor: 5.226

7.  A monoclonal antibody for distinction of invasive and noninvasive clinical isolates of Entamoeba histolytica.

Authors:  A Gonzalez-Ruiz; R Haque; T Rehman; A Aguirre; C Jaramillo; G Castañon; A Hall; F Guhl; G Ruiz-Palacios; D C Warhurst
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

8.  Analysis of pathogenicity by restriction-endonuclease digestion of amplified genomic DNA of Entamoeba histolytica isolated in Pernambuco, Brazil.

Authors:  H Tachibana; S Kobayashi; K C Paz; I S Aca; S Tateno; S Ihara
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

9.  Application of the polymerase chain reaction to the epidemiology of pathogenic and nonpathogenic Entamoeba histolytica.

Authors:  R Acuna-Soto; J Samuelson; P De Girolami; L Zarate; F Millan-Velasco; G Schoolnick; D Wirth
Journal:  Am J Trop Med Hyg       Date:  1993-01       Impact factor: 2.345

Review 10.  A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925.

Authors:  L S Diamond; C G Clark
Journal:  J Eukaryot Microbiol       Date:  1993 May-Jun       Impact factor: 3.346

View more
  5 in total

1.  Preparation of recombinant human monoclonal antibody Fab fragments specific for Entamoeba histolytica.

Authors:  H Tachibana; X J Cheng; K Watanabe; M Takekoshi; F Maeda; S Aotsuka; Y Kaneda; T Takeuchi; S Ihara
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Detection and differentiation of Entamoeba histolytica and Entamoeba dispar isolates in clinical samples by PCR and enzyme-linked immunosorbent assay.

Authors:  Patrick Gonin; Louise Trudel
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

3.  Bacterial expression of a human monoclonal antibody-alkaline phosphatase conjugate specific for Entamoeba histolytica.

Authors:  Hiroshi Tachibana; Masataka Takekoshi; Xun-Jia Cheng; Yuta Nakata; Tsutomu Takeuchi; Seiji Ihara
Journal:  Clin Diagn Lab Immunol       Date:  2004-01

4.  Diagnosis of intestinal amoebiasis by using nested polymerase chain reaction-restriction fragment length polymorphism assay.

Authors:  Krishna Khairnar; Subhash Chandra Parija; Ravisankar Palaniappan
Journal:  J Gastroenterol       Date:  2007-08-24       Impact factor: 7.527

5.  Characterization of Entamoeba histolytica intermediate subunit lectin-specific human monoclonal antibodies generated in transgenic mice expressing human immunoglobulin loci.

Authors:  Hiroshi Tachibana; Xun-Jia Cheng; Hideo Tsukamoto; Johbu Itoh
Journal:  Infect Immun       Date:  2008-11-10       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.